SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue128,367146,444162,556
Cost of Revenue47,21835,84327,689
Gross Profit81,149110,601134,867
Operating Expenses
Research Development65,89559,12351,073
Selling General and Administrative84,26788,41888,064
Non Recurring---
Others27,64725,94638,319
Total Operating Expenses---
Operating Income or Loss-96,660-62,886-42,589
Income from Continuing Operations
Total Other Income/Expenses Net-4,568238-573
Earnings Before Interest and Taxes-101,228-62,648-43,162
Interest Expense6,7989,4359,074
Income Before Tax-108,026-72,083-52,236
Income Tax Expense-16,778-2,313406
Minority Interest---
Net Income From Continuing Ops-91,248-69,770-52,642
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-91,248-69,770-52,642
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-91,248-69,770-52,642